
Naltrexone vs. Topiramate: FDA-Approved vs. Off-Label Options for MAUD
30 Jun 2025
• 10 min
• EN
In this episode, we explore groundbreaking head-to-head research comparing topiramate and naltrexone for alcohol use disorder, revealing surprising equivalence in effectiveness. Could the off-label option actually be as good as our FDA-approved standard for treating problematic drinking? Faculty: David Gorelick, M.D. Host: Richard Seeber, M.D. Learn more about our membership here Earn 0.5 CME: Quick Take Vol. 69 Can Topiramate Replace FDA-Approved Medications for Alcohol Use Disorder?
From "Psychopharmacology and Psychiatry Updates"
Comments
Add comment Feedback